See Our Current Investments

Immediate Upside? WHK Reveals Future Revenue Growth

  Article Oct 30, 2020

One of our long-term portfolio stocks, WhiteHawk Ltd (ASX: WHK) has just delivered its quarterly report to the market, and the results show WHK is on the right path to sustained growth.

$31M ASX Small Cap Telco Posts $16.7M Annual Recurring

  Article Oct 30, 2020

Recurring revenue, facilitated by the acquisition of 2SG, has provided Vonex with forward earnings predictability. The 2SG acquisition cannot be underestimated, having provided Vonex (ASX: VN8) with substantial sales momentum.

This ASX Stock is Almost at Our BUY Price

  Email Oct 27, 2020

After surging to almost $1.50, one of our long term portfolio companies, MyFiziq Ltd (ASX: MYQ), has just dipped close to our most recent entry price. We believe the current MYQ share price provides an attractive entry point for new investors given that in the last four weeks MYQ has:

NASDAQ Listing a Step Closer as MYQ Secures $5M to Forge Forward

  Article Oct 14, 2020

MyFiziq (ASX: MYQ) recently appointed NYSE stalwart Ladenburg Thalmann & Co. Inc. to facilitate the NASDAQ listing which would open up a huge market segment to this health tech provider.

WHK Secures A$2.1M US Government Contract Extension

  Article Oct 07, 2020

WhiteHawk Ltd (ASX: WHK) has been awarded a US$1.5 million (A$2.1M) contract extension with a US federal government department, validating its cybersecurity technology and value to the US government in combatting cyber threats.

US$3.5M Revenue per Year Guaranteed – MYQ’s New Deal is a Company Maker

  Article Oct 06, 2020

Today, MyFiziq (ASX: MYQ) has announced that it has signed a binding term sheet with Nexus-Vita Singapore, a health monitoring and management technology company that will guarantee MYQ minimum annual revenue to MYQ of US$3,588,000 per annum, from the date of commercial launch of its app.

Meet Our Latest ASX Tech Portfolio Addition: VN8 is a Company Transformed

  Article Sep 25, 2020

After following the story for a while, and having familiarised ourselves with management and the company, we have decided to take a long-term position in Vonex (ASX: VN8).

Our Favourite Health Tech Stock Soars to 85 Cents on Major Milestone Hits

  Article Sep 18, 2020

The Next Tech Stock first alerted you to emerging health tech small cap MyFiziq (ASX: MYQ) back in April, when the stock was just 11.5 cents. This week, the company hit $1.00 a 769% increase, since we first initiated coverage and took a significant long-term investment to make MYQ one of our biggest holdings.

ROO Chases Plant Based Meat Opportunities Following Key Hire

  Article Aug 28, 2020

Roots Sustainable Agriculture Technologies Ltd (ASX: ROO) new plant-based meat department will focus on collaboration with industry partners to further commercialise RZTO technology with growers and manufacturers.

88% Revenue Growth for Vonex (ASX: VN8) - More Upside Ahead?

  Article Aug 11, 2020

Vonex (ASX: VN8) demonstrated an 88% increase in annualised recurring revenue during fiscal 2020 to $16.4 million. The acquisition of 2SG has also been one of the company’s key achievements.

WhiteHawk Wins US Federal Government Cybersecurity Contract Worth up to US$5.9M

  Article Jul 28, 2020

WhiteHawk (ASX: WHK) announced it has been contracted by a key US federal government Chief Information Security Officer (CISO) to implement its Cyber Risk Radar. The annual Software as a Service (SaaS) contract, will see WhiteHawk generate total of up to US$1.18 million (A$1.65M) for each year of the contract.

A Wave of Cyber Attacks has Whitehawk (ASX: WHK) Primed to Run

  Article Jun 22, 2020

Cybersecurity is in the spotlight after last week’s unprecedented malicious cyber attack on Australian by an “unnamed state-based actor”. WhiteHawk Ltd (ASX: WHK) is in our view the most compelling ASX-listed cybersecurity stock.

CM8 Signs Vital European Sales Agreement for High Demand Healthcare Products

  Article Jun 16, 2020

Crowd Media Holdings Limited (ASX:CM8 | FWB:CM3) and VITAL have joined together with a two-year exclusive and binding Marketing Services Agreement to market and sell key VITAL portfolio brands and products into the European market

MYQ Unlocks Revenue via Evolt's Apple App Store Launch

  Article Jun 09, 2020

Today’s launch of the MyFiziq (ASX: MYQ)/Evolt integration on the Apple app store is a significant milestone. The MyFiziq technology is intended to extend Evolt’s reach into put the app into hands of Evolt’s 500,000 home-based consumers.

Could a NASDAQ Listing Put MYQ on the US Health & Fitness Map?

  Article Jun 01, 2020

Software as a service (SaaS) solution provider MyFiziq Limited (ASX: MYQ) is set for a secondary listing on the NASDAQ Capital Market.

WHK Expands its Cyber Risk Program, Delivers Huge Lift in Revenues

  Article Apr 30, 2020

Cybersecurity solutions provider WhiteHawk has lifted its revenues by 55% from the previous quarter and 282% from a year earlier.

AJX Partners with US$15B Giant to Commercialise its Flame Retardant Chemistries

  Article Apr 27, 2020

Alexium International Group Limited (ASX: AJX) has joined forces with a major flame retardant chemical company, combining their technical and market resources to launch Alexiflam® NF into target markets.

ASX Listed Tech Stock’s Health App Can Help Fight Obesity and COVID-19

  Article Apr 20, 2020

MyFiziq's (ASX: MYQ) technology allows for the easy collection and comparison of measurements for clothing, weight management, athletic goals, and the medical field treating illnesses such as diabetes and obesity..

CLICK HERE TO VIEW OUR CURRENT PORTFOLIO
Are you a sophisticated investor?
Find out more
Please note: Raisebook is a related entity of S3 Consortium Pty Ltd as defined in Section 9 of the Corporations Act 2001.
EXR Emerging from Post Placement Price Pressure

Be the first to find out about our next investment.

Thanks for subscribing!

X